#8704 on the rich list of 14,644 insiders
Chris Freeman
Chief Commercial Officer at Guardant Health. Based in Palo Alto, California.
$10.2M
in disclosed stock, +$51K (+0.50%) today
Live prices, last trade 3:22 PM ET
- Rank
- 8704th of 14,644
- Companies held
- 1
- Largest holding
- GH, 100.0% of total
- Latest SEC filing
- Oct 1, 2026
What the $10.2M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Guardant Health GH Common Stock | Directly | 69,647 | $145.87 | $10.2M | 100.0% | Form 4, Oct 1, 2026 |
Share counts are the amounts Chris Freeman reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
| Date | Trade | Company | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 10, 2026 | Sold | GH | 35,364 | $169.63 | $6.0M | View |
| Aug 10, 2026 | Sold | GH | 7,365 | $168.79 | $1.2M | View |
| Aug 10, 2026 | Sold | GH | 3,463 | $167.38 | $580K | View |
| Aug 10, 2026 | Sold | GH | 17,413 | $170.24 | $3.0M | View |
| May 22, 2026 | Sold | GH | 24,406 | $118.67 | $2.9M | View |
| Dec 5, 2025 | Sold | GH | 744 | $102.31 | $76K | View |
| Dec 5, 2025 | Sold | GH | 478 | $101.43 | $48K | View |
| Dec 5, 2025 | Sold | GH | 2,964 | $106.71 | $316K | View |
| Dec 5, 2025 | Sold | GH | 400 | $105.99 | $42K | View |
| Dec 5, 2025 | Sold | GH | 6,555 | $103.97 | $682K | View |
| Dec 5, 2025 | Sold | GH | 372 | $103.48 | $38K | View |
| Dec 5, 2025 | Sold | GH | 11,969 | $102.09 | $1.2M | View |
| Dec 5, 2025 | Sold | GH | 4,084 | $101.40 | $414K | View |
| Dec 5, 2025 | Sold | GH | 228 | $106.63 | $24K | View |
| Dec 5, 2025 | Sold | GH | 244 | $104.10 | $25K | View |
| Dec 5, 2025 | Sold | GH | 3,414 | $103.25 | $352K | View |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 8701 | Kenneth R. Chappell Director, West Coast Community Bancorp. Santa Cruz, CA | $10.2M |
| 8702 | Michael Zachary Brous CHIEF FINANCIAL OFFICER, Lyft. San Francisco, CA | $10.2M |
| 8703 | Betty R. Wynn Senior VP, MYR Group. Bismarck, ND | $10.2M |
| 8704 | Chris Freeman Chief Commercial Officer, Guardant Health. Palo Alto, CA | $10.2M |
| 8705 | Tatsuya Akimoto 10% owner, Advasa Holdings | $10.2M |
| 8706 | David Joseph Gaffin EVP, CLO, Alkermes, Inc., Alkermes. Waltham, MA | $10.2M |
| 8707 | Matthew Maxwell Donley Chief Operating Officer, Aurinia Pharmaceuticals | $10.2M |
Other Guardant Health insiders
All GH insiders- AmirAli Talasaz$604MCo-Chief Executive Officer. #422 overall
- Helmy Eltoukhy$591MCo-Chief Executive Officer. #430 overall
- Darya Chudova$20.2MChief Technology Officer. #5164 overall
- Craig Eagle$10.5MChief Medical Officer. #8361 overall
- Michael Brian Bell$8.0MChief Financial Officer. #10349 overall
- Kumud Kalia$6.2MChief Information Officer. #12451 overall
Questions
How much stock does Chris Freeman own?
Chris Freeman holds $10,159,408 in listed stock based on SEC filings and current prices, mostly Guardant Health (GH). That ranks 8704th on the Stock Rich List.
Is this Chris Freeman's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Chris Freeman last buy or sell stock?
The most recent open-market trade on file is a sale of 35,364 GH shares on Aug 10, 2026 at $169.63.